Bioventus (BVS) Income towards Parent Company (2020 - 2026)

Bioventus has reported Income towards Parent Company for 6 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 218.78% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $34.5 million (up 1139.8% YoY), and the FY2023 full-year result was -$74.4 million, down 8.28% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $3.9 million, down from $17.3 million in the prior quarter.
• The five-year high for Income towards Parent Company was $17.3 million in Q4 2025, with the low at -$74.4 million in Q2 2023.
• Historically, Income towards Parent Company has averaged -$11.2 million across 4 years, with a median of -$340500.0 in 2022.
• Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 93484.0% — and 2026, when it jumped 218.78%.
• Bioventus' Income towards Parent Company stood at -$23.4 million in 2022, then plunged by 218.13% to -$74.4 million in 2023, then soared by 123.27% to $17.3 million in 2025, then sank by 77.21% to $3.9 million in 2026.
• The last three Income towards Parent Company figures came in at $3.9 million (Q1 2026), $17.3 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.